CYCLOPHOSPHAMIDE OR DENILEUKIN DIFTITOX FOLLOWED BY EXPANDING A PATIENT'S OWN T CELLS IN THE LABORATORY IN TREATING PATIENTS WITH HER-2/NEU OVEREXPRESSING METASTATIC BREAST CANCER, OVARIAN CANCER, OR NON-SMALL CELL LUNG CANCER PREVIOUSLY TREATED WITH HER-2/NEU VACCINE: